4//SEC Filing
Stimart Tryn 4
Accession 0000899243-20-034339
CIK 0001703057other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 8:30 PM ET
Size
12.3 KB
Accession
0000899243-20-034339
Insider Transaction Report
Form 4
Stimart Tryn
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2020-12-10+190,800→ 190,800 totalExercise: $20.00Exp: 2030-12-10→ Common Shares (190,800 underlying) - Purchase
Common Shares
2020-12-15$20.00/sh+250$5,000→ 250 total - Purchase
Common Shares
2020-12-15$20.00/sh+250$5,000→ 250 total(indirect: By Spouse) - Award
Stock Option (right to buy)
2020-10-29+850,000→ 850,000 totalExercise: $2.41Exp: 2030-10-29→ Common Shares (850,000 underlying)
Footnotes (5)
- [F1]On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.
- [F2]The exercise price reported above was converted from the Canadian exercise price of CAD $3.08 using an exchange rate of CAD $1.27840 = US $1.00.
- [F3]25% of the shares subject to such option vest and become exercisable on October 29, 2021 and the remainder of the shares vest in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
- [F4]25% of the shares subject to such option vest and become exercisable on December 31, 2021 and the remainder of the shares vest in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
- [F5]This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.
Documents
Issuer
AbCellera Biologics Inc.
CIK 0001703057
Entity typeother
Related Parties
1- filerCIK 0001834424
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 8:30 PM ET
- Size
- 12.3 KB